178 related articles for article (PubMed ID: 25200803)
21. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
Mullins CD; Rattinger GB; Kuznik A; Koren MJ
Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
[TBL] [Abstract][Full Text] [Related]
22. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
Kwong WJ; Kamat S; Fang C
Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
[TBL] [Abstract][Full Text] [Related]
23. Effect of generic-only drug benefits on seniors' medication use and financial burden.
Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
[TBL] [Abstract][Full Text] [Related]
24. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
Kesselheim AS; Misono AS; Lee JL; Stedman MR; Brookhart MA; Choudhry NK; Shrank WH
JAMA; 2008 Dec; 300(21):2514-26. PubMed ID: 19050195
[TBL] [Abstract][Full Text] [Related]
25. [Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia].
Mainar AS; Artieda RN
Gac Sanit; 2010; 24(6):473-82. PubMed ID: 20970220
[TBL] [Abstract][Full Text] [Related]
26. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
[TBL] [Abstract][Full Text] [Related]
27. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
Am J Ther; 2011; 18(2):110-6. PubMed ID: 20216383
[TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy, safety, and pharmaco-economical aspects of the therapy for dyslipidemia with brand-name and generic statins].
Ol'binskaia LI; Danilogorskaia IuA
Ter Arkh; 2003; 75(12):47-50. PubMed ID: 14959470
[TBL] [Abstract][Full Text] [Related]
30. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
[TBL] [Abstract][Full Text] [Related]
31. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
[TBL] [Abstract][Full Text] [Related]
32. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care.
Federman AD; Halm EA; Siu AL
Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772
[TBL] [Abstract][Full Text] [Related]
33. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin.
Sicras-Mainar A; Rejas-Gutiérrez J; Pérez-Paramo M; Sánchez-Alvarez L; Navarro-Artieda R; Darbà J
Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):45-57. PubMed ID: 30182806
[TBL] [Abstract][Full Text] [Related]
34. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
Hoadley JF; Merrell K; Hargrave E; Summer L
Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.
Hess G; Sanders KN; Hill J; Liu LZ
Am J Manag Care; 2007 Jun; 13 Suppl 3():S80-5. PubMed ID: 17596116
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of generic versus brand-name antiepileptic medications.
Gagne JJ; Kesselheim AS; Choudhry NK; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Epilepsy Behav; 2015 Nov; 52(Pt A):14-8. PubMed ID: 26386779
[TBL] [Abstract][Full Text] [Related]
39. Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study.
Patel MS; Day S; Small DS; Howell JT; Lautenbach GL; Nierman EH; Volpp KG
Ann Intern Med; 2014 Nov; 161(10 Suppl):S44-52. PubMed ID: 25402402
[TBL] [Abstract][Full Text] [Related]
40. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]